NCT07245381 2025-11-24
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
Sheba Medical Center
Phase 1/2 Not yet recruiting
Clinical Trials
10 trialsNCT00019695 2024-03-04
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT02304757 2021-11-17
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Completed
NCT02781805 2020-10-22
Pilot Study of Bisphosphonates for Breast Cancer
University of Wisconsin, Madison
Phase 1 Terminated
NCT00354302 2020-04-02
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
Canadian Cancer Trials Group
Phase 3 Completed
NCT00177619 2014-02-11
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)
University of Pittsburgh
Phase 3 Completed
NCT00593580 2011-06-29
FOSAVANCE
British Columbia Cancer Agency
Phase 2 Completed
NCT00048841 2010-03-02
Prevention of Osteoporosis in Men With Prostate Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3 Completed
NCT00236002 2009-08-12
Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
Canadian Urology Research Consortium
Phase 3 Terminated
NCT00391404 2008-05-23
Fosamax for Childhood Cancer Survivors
Chinese University of Hong Kong
Phase 3 Unknown